CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 186 filers reported holding CYTOKINETICS INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $10,788,000 | -47.4% | 545,101 | -38.2% | 1.46% | -40.7% |
| Q1 2021 | $20,513,000 | -31.3% | 881,901 | -38.6% | 2.46% | -24.2% |
| Q4 2020 | $29,840,000 | -17.6% | 1,435,992 | -14.1% | 3.24% | -60.3% |
| Q3 2020 | $36,205,000 | -4.4% | 1,672,292 | +4.0% | 8.16% | -55.8% |
| Q2 2020 | $37,884,000 | +47.6% | 1,607,292 | -26.2% | 18.46% | -41.7% |
| Q1 2020 | $25,670,000 | +0.9% | 2,177,292 | -9.2% | 31.64% | +188.1% |
| Q4 2019 | $25,453,000 | +17.8% | 2,398,970 | +26.3% | 10.98% | +57.2% |
| Q3 2019 | $21,610,000 | +1.2% | 1,898,970 | 0.0% | 6.98% | +15.7% |
| Q2 2019 | $21,363,000 | +53.2% | 1,898,970 | +10.2% | 6.04% | +20.5% |
| Q1 2019 | $13,940,000 | +1159.3% | 1,723,170 | +883.8% | 5.01% | +886.2% |
| Q4 2018 | $1,107,000 | – | 175,148 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |